Pulmonary embolism (PE) is a serious and potentially life-threatening medical condition that affects many people around the world. It is caused when a blood clot travels to the lungs, blocking the flow of oxygenated blood and resulting in potentially fatal complications. PE is also known as the “silent killer” because it often has no warning signs or symptoms and can be difficult to diagnose. It is important for doctors to understand the risk factors associated with PE and to be able to recognize the signs and symptoms in order to provide timely and effective treatment.
Pulmonary embolism is a medical emergency that occurs when a blockage, usually a blood clot, travels from one part of the body to the lungs. The blockage, called an embolus, can be caused by a variety of factors, including deep vein thrombosis (DVT), which is a clot in the veins of the leg. The embolus lodges in the pulmonary arteries, blocking the flow of oxygenated blood to the lungs. This can cause a variety of serious complications, including difficulty breathing, chest pain, and even death.
There are several risk factors that can increase the likelihood of developing pulmonary embolism. These include: • Age: People over the age of 60 are more likely to develop PE than younger individuals. • Gender: Women are more likely to develop PE than men. • Obesity: People who are overweight or obese are at a higher risk for developing PE. • Smoking: Smoking increases the risk of developing PE. • Inactivity: People who are sedentary or who have a history of long periods of inactivity are at a higher risk for developing PE. • Family history: People with a family history of blood clots or PE are more likely to develop PE. • Surgery: People who have recently had surgery, especially major surgery, are at an increased risk of developing PE. • Pregnancy: Pregnant women are more likely to develop PE due to changes in blood flow and clotting factors.
The signs and symptoms of PE can vary from person to person and can range from mild to severe. Some of the most common symptoms include: • Shortness of breath • Chest pain • Coughing • Sweating • Rapid heart rate • Lightheadedness • Fainting It is important to note that some people may not experience any symptoms at all, making PE even more difficult to diagnose.
In order to diagnose PE, doctors will typically use a combination of tests, including a physical exam, chest X-ray, CT scan, echocardiogram, and blood tests. Treatment for PE usually involves the use of anticoagulant medications to help prevent the formation of new clots and to reduce the risk of further complications. In some cases, surgery may be required to remove the clot from the lungs.
Pulmonary embolism is a serious and potentially life-threatening medical condition that affects many people around the world. It is important for doctors to be aware of the risk factors associated with PE and to be able to recognize the signs and symptoms in order to provide timely and effective treatment. With early diagnosis and treatment, the risk of serious complications and death can be greatly reduced.
1.
Electronic Sepsis Alerts; Reducing Plaques in Coronary Arteries
2.
Ivonescimab Tops Pembrolizumab in PD-L1-Positive, Advanced NSCLC
3.
Hereditary cancer has a rare and underreported cause.
4.
New imaging guidelines for head and neck cancers, a step toward practice change
5.
BMTs that are "half-matched" are effective in treating severe sickle cell disease.
1.
Oncolytic Adenoviruses Targeting PD-L1: Advancing Cancer Immunotherapy and Tumor Control
2.
Personalized Cancer Vaccines: The Next Frontier in Precision Oncology
3.
Essential Updates in Hematology in Daily Practice
4.
The Predictive Power of Theranostics in Palliative Neuroendocrine Tumor Management
5.
Importance of Early Detection in Oncology
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I
3.
Current Scenario of Cancer- The Incidence of Cancer in Men
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV
5.
A New Era in Managing Cancer-Associated Thrombosis
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation